 |
The Journal of Neuroscience, April 21, 2004, 24(16):4020-4029; doi:10.1523/JNEUROSCI.5531-03.2004
Previous Article | Next Article 
Behavioral/Systems/Cognitive
Corticotropin-Releasing Factor and Urocortin I Modulate Excitatory Glutamatergic Synaptic Transmission
Jie Liu,1
Baojian Yu,1
Volker Neugebauer,1
Dimitri E. Grigoriadis,2
Jean Rivier,3
Wylie W. Vale,3
Patricia Shinnick-Gallagher,1 and
Joel P. Gallagher1
1Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555-1031, 2Neurocrine Biosciences Incorporated, San Diego, California 92121, and 3Clayton Foundation Laboratories for Peptide Biology, The Salk Institute for Biological Studies, Peptide Biology Laboratory, La Jolla, California 92037
Corticotropin-releasing factor (CRF)-related peptides serve as hormones and neuromodulators of the stress response and play a role in affective disorders. These peptides are known to alter complex behaviors and neuronal properties, but their receptor-mediated effects at CNS synapses are not well described. Here we show that excitatory glutamatergic transmission is modulated by two endogenous CRF-related peptide ligands, corticotropin-releasing factor [CRF rat/human (r/h)] and Urocortin I (Ucn I), within the central nucleus of the amygdala (CeA) and the lateral septum mediolateral nucleus (LSMLN). These limbic nuclei are reciprocally innervated, are involved in stress and affective disorders, and have high densities of the CRF receptors CRF1 and CRF2. Activation of these receptors exerts diametrically opposed actions on glutamatergic transmission in these nuclei. In the CeA, CRF(r/h) depressed excitatory glutamatergic transmission through a CRF1-mediated postsynaptic action, whereas Ucn I facilitated synaptic responses through presynaptic and postsynaptic CRF2-mediated mechanisms. Conversely, in the LSMLN, CRF caused a CRF1-mediated facilitation of glutamatergic transmission via postsynaptic mechanisms, whereas Ucn I depressed EPSCs by postsynaptic and presynaptic CRF2-mediated actions. Furthermore, antagonists of these receptors also affected glutamatergic neurotransmission, indicating that endogenous ligands tonically modulated synoptic activity at these synapses.
These data show that CRF receptors in CeA and LSMLN synapses exert and maintain a significant synaptic tone and thereby regulate excitatory glutamatergic transmission. The results also suggest that CRF receptors may provide novel targets in affective disorders and stress.
Key words: CRF; amygdala; lateral septum; glutamatergic synaptic transmission; synaptic homeostasis; urocortin
Received July 18, 2003;
revised March 10, 2004;
accepted March 10, 2004.
This article has been cited by other articles:

|
 |

|
 |
 
Y. Fu and V. Neugebauer
Differential Mechanisms of CRF1 and CRF2 Receptor Functions in the Amygdala in Pain-Related Synaptic Facilitation and Behavior
J. Neurosci.,
April 9, 2008;
28(15):
3861 - 3876.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Larauche, S. Bradesi, M. Million, P. McLean, Y. Tache, E. A. Mayer, and J. A. McRoberts
Corticotropin-releasing factor type 1 receptors mediate the visceral hyperalgesia induced by repeated psychological stress in rats
Am J Physiol Gastrointest Liver Physiol,
April 1, 2008;
294(4):
G1033 - G1040.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Ji and V. Neugebauer
Pro- and Anti-Nociceptive Effects of Corticotropin-Releasing Factor (CRF) in Central Amygdala Neurons Are Mediated Through Different Receptors
J Neurophysiol,
March 1, 2008;
99(3):
1201 - 1212.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Orozco-Cabal, J. Liu, S. Pollandt, K. Schmidt, P. Shinnick-Gallagher, and J. P. Gallagher
Dopamine and Corticotropin-Releasing Factor Synergistically Alter Basolateral Amygdala-to-Medial Prefrontal Cortex Synaptic Transmission: Functional Switch after Chronic Cocaine Administration
J. Neurosci.,
January 9, 2008;
28(2):
529 - 542.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zhao, G. R. Valdez, E. M. Fekete, J. E. Rivier, W. W. Vale, K. C. Rice, F. Weiss, and E. P. Zorrilla
Subtype-Selective Corticotropin-Releasing Factor Receptor Agonists Exert Contrasting, but Not Opposite, Effects on Anxiety-Related Behavior in Rats
J. Pharmacol. Exp. Ther.,
December 1, 2007;
323(3):
846 - 854.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Cheng, L. Zhou, W. Zhu, A. Wang, C. Tang, O. Chan, R. S. Sherwin, and R. J. McCrimmon
Type 1 corticotropin-releasing factor receptors in the ventromedial hypothalamus promote hypoglycemia-induced hormonal counterregulation
Am J Physiol Endocrinol Metab,
September 1, 2007;
293(3):
E705 - E712.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Fu, S. Pollandt, J. Liu, B. Krishnan, K. Genzer, L. Orozco-Cabal, J. P. Gallagher, and P. Shinnick-Gallagher
Long-Term Potentiation (LTP) in the Central Amygdala (CeA) Is Enhanced After Prolonged Withdrawal From Chronic Cocaine and Requires CRF1 Receptors
J Neurophysiol,
January 1, 2007;
97(1):
937 - 941.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Liu, B. Yu, L. Orozco-Cabal, D. E. Grigoriadis, J. Rivier, W. W. Vale, P. Shinnick-Gallagher, and J. P. Gallagher
Chronic Cocaine Administration Switches Corticotropin-Releasing Factor2 Receptor-Mediated Depression to Facilitation of Glutamatergic Transmission in the Lateral Septum
J. Neurosci.,
January 19, 2005;
25(3):
577 - 583.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Guillemin
Hypothalamic hormones a.k.a. hypothalamic releasing factors
J. Endocrinol.,
January 1, 2005;
184(1):
11 - 28.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|